https://european-biotechnology.com/wp-content/uploads/2024/04/Cradle_Team.jpg10791440Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-11-28 09:44:082024-07-09 12:55:45AI protein specialist Cradle raises US$24m in Series A financing
British and Italian researchers have demostrated promising results in patients with progressive multiple sclerosis through stem cell transplantation into the brain.
Flagship Pioneering has committed US$50m to launch Quotient Therapeutics that links genetic variation at cellular level with disease by Nanoseq, a sequencing method licenced from the Wellcome Sanger Institute.
Finnish protein maker Solar Foods has closed an oversubscribed €8M Series B financing and will expand Solein protein production and support the construction of a commercial production plant.
https://european-biotechnology.com/wp-content/uploads/2024/04/solar-foods2.jpg7681024Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-11-21 09:36:402024-07-09 12:38:23Solar Foods raises €8m in Series B financing
https://european-biotechnology.com/wp-content/uploads/2024/04/Microharvest2-scaled.jpg17072560Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-11-20 08:52:592024-07-09 13:19:33Germany boosts protein transition with €38m
German precision fermentation specialist MicroHarvest GmbH has launched a single-cell protein pilot plant in Lison with an initial capacity of 25kg per day.
The biotech company Cellaïon, based in the Walloon biotechnology valley in Mont-St-Guibert, Belgium, has appointed a new CEO: Dr James Neil Phillips has taken on the role, succeeding Cellaïon’s founder Etienne Sokal.
https://european-biotechnology.com/wp-content/uploads/2024/04/EBcom_James_Neill_Phillips.jpg472420Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-11-16 10:00:002024-05-24 14:30:36New CEO for Cellaïon
AI protein specialist Cradle raises US$24m in Series A financing
Latest NewsGenerative AI protein engineering specialist Cradle NV, has raised US$24m in a Series A financing round led by Index Ventures w
Repairing MS-caused damage with stem cells
Latest NewsBritish and Italian researchers have demostrated promising results in patients with progressive multiple sclerosis through stem cell transplantation into the brain.
Breakthrough in COPD treatment
Latest NewsFrench Sanofi SA’s second Phase III trial of duplimab demonstrated a 34% reduction in exacerbations and significant lung function improvements.
Novo Nordisk invests €2.1bn in production expansion
Latest NewsIn the race for global market share of its obesity and diabetes blockbuster semaglutide, Novo Nordisk is expanding production in Europe.
Quotient Therapeutics kicks-off with US$50m financing
Latest NewsFlagship Pioneering has committed US$50m to launch Quotient Therapeutics that links genetic variation at cellular level with disease by Nanoseq, a sequencing method licenced from the Wellcome Sanger Institute.
Enhance3D Genomics expands leadership team
AppointmentsCambridge-based Enhanc3D Genomics announced the appointment of Hazel Jones as Chief Operating Officer at beginning of November.
Solar Foods raises €8m in Series B financing
Latest NewsFinnish protein maker Solar Foods has closed an oversubscribed €8M Series B financing and will expand Solein protein production and support the construction of a commercial production plant.
Germany boosts protein transition with €38m
Latest NewsThe Budget Committee of the German Bundestag has announced to channel €38m in funding into the sustainable protein transition next year.
Microharvest GmbH launches SCP-Pilot plant in Lissabon
Latest NewsGerman precision fermentation specialist MicroHarvest GmbH has launched a single-cell protein pilot plant in Lison with an initial capacity of 25kg per day.
New CEO for Cellaïon
AppointmentsThe biotech company Cellaïon, based in the Walloon biotechnology valley in Mont-St-Guibert, Belgium, has appointed a new CEO: Dr James Neil Phillips has taken on the role, succeeding Cellaïon’s founder Etienne Sokal.